Nathan Roth

2.9k total citations
103 papers, 1.5k citations indexed

About

Nathan Roth is a scholar working on Molecular Biology, Clinical Psychology and Infectious Diseases. According to data from OpenAlex, Nathan Roth has authored 103 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 22 papers in Clinical Psychology and 18 papers in Infectious Diseases. Recurrent topics in Nathan Roth's work include Psychotherapy Techniques and Applications (17 papers), Virus-based gene therapy research (10 papers) and Enzyme Catalysis and Immobilization (10 papers). Nathan Roth is often cited by papers focused on Psychotherapy Techniques and Applications (17 papers), Virus-based gene therapy research (10 papers) and Enzyme Catalysis and Immobilization (10 papers). Nathan Roth collaborates with scholars based in United States, Germany and Switzerland. Nathan Roth's co-authors include R.E. Huber, Adam Szulewski, Daniel Howes, Wolfram Schäfer, Albrecht Gröner, Carlos Ros, Eleonora Widmer, Toby L. Simon, Thomas Nowak and Douglas C. Lee and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and American Journal of Psychiatry.

In The Last Decade

Nathan Roth

85 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nathan Roth United States 20 415 223 207 183 178 103 1.5k
Heinz Hartmann Germany 29 1.3k 3.2× 225 1.0× 136 0.7× 129 0.7× 102 0.6× 87 3.6k
Elizabeth Flanagan United States 21 516 1.2× 102 0.5× 80 0.4× 78 0.4× 219 1.2× 64 1.5k
Simon Lai Hong Kong 24 390 0.9× 211 0.9× 132 0.6× 95 0.5× 306 1.7× 66 2.0k
Jean‐Philippe Antonietti Switzerland 21 409 1.0× 68 0.3× 105 0.5× 224 1.2× 175 1.0× 85 1.5k
Rachel Anderson United States 27 336 0.8× 270 1.2× 168 0.8× 450 2.5× 309 1.7× 68 2.3k
Elizabeth A. Hart United Kingdom 17 745 1.8× 495 2.2× 66 0.3× 133 0.7× 92 0.5× 19 2.0k
Nelly Zilber Israel 26 746 1.8× 175 0.8× 42 0.2× 53 0.3× 411 2.3× 73 2.0k
Kenneth W. Jones United States 22 66 0.2× 317 1.4× 198 1.0× 58 0.3× 449 2.5× 57 2.5k
Susan Johnson United States 31 334 0.8× 140 0.6× 616 3.0× 244 1.3× 90 0.5× 63 3.4k
Ilaria Castelli Italy 26 400 1.0× 242 1.1× 650 3.1× 45 0.2× 203 1.1× 111 2.3k

Countries citing papers authored by Nathan Roth

Since Specialization
Citations

This map shows the geographic impact of Nathan Roth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nathan Roth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nathan Roth more than expected).

Fields of papers citing papers by Nathan Roth

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nathan Roth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nathan Roth. The network helps show where Nathan Roth may publish in the future.

Co-authorship network of co-authors of Nathan Roth

This figure shows the co-authorship network connecting the top 25 collaborators of Nathan Roth. A scholar is included among the top collaborators of Nathan Roth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nathan Roth. Nathan Roth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dähnert, Lisa, Josephine Schlosser, Christine Fast, et al.. (2021). Hepatitis E virus: Efficacy of pasteurization of plasma‐derived VWF/FVIII concentrate determined by pig bioassay. Transfusion. 61(4). 1266–1277. 5 indexed citations
2.
Schemmerer, Mathias, et al.. (2021). Hepatitis A Virus Incidence Rates and Biomarker Dynamics for Plasma Donors, United States. Emerging infectious diseases. 27(11). 2718–2824. 4 indexed citations
3.
Schemmerer, Mathias, et al.. (2021). Hepatitis A Virus Incidence Rates and Biomarker Dynamics for Plasma Donors, United States. Emerging infectious diseases. 27(11). 2718–2824.
4.
Barnes, Thomas W., Johannes Schulte-Pelkum, Christina Kober, et al.. (2021). Determination of neutralising anti-SARS-CoV-2 antibody half-life in COVID-19 convalescent donors. Clinical Immunology. 232. 108871–108871. 12 indexed citations
5.
Sibley, Stephanie, Nathan Roth, Charles Scott, et al.. (2020). Point-of-care ultrasound for the detection of hydronephrosis in emergency department patients with suspected renal colic. The Ultrasound Journal. 12(1). 31–31. 29 indexed citations
6.
Roth, Nathan, et al.. (2020). Determination of parvovirus retention profiles in virus filter membranes using laser scanning microscopy. Journal of Membrane Science. 603. 118012–118012. 13 indexed citations
8.
Simon, Toby L., et al.. (2019). Manufacturing of plasma-derived C1-inhibitor concentrate for treatment of patients with hereditary angioedema. Allergy and Asthma Proceedings. 41(2). 99–107. 8 indexed citations
9.
Szulewski, Adam, Nathan Roth, & Daniel Howes. (2015). The Use of Task-Evoked Pupillary Response as an Objective Measure of Cognitive Load in Novices and Trained Physicians. Academic Medicine. 90(7). 981–987. 65 indexed citations
10.
Penner, Reginald M., et al.. (1999). Tyr-503 of β-galactosidase (Escherichia coli) plays an important role in degalactosylation. Biochemistry and Cell Biology. 77(3). 229–236. 15 indexed citations
11.
Roth, Nathan & R.E. Huber. (1996). GLU-416 of β-Galactosidase (Escherichia coli) Is a MG2+Ligand and β-Galactosidases with Substitutions for GLU-416 Are Inactivated, Rather than Activated, by MG2+. Biochemical and Biophysical Research Communications. 219(1). 111–115. 15 indexed citations
12.
Roth, Nathan & R.E. Huber. (1996). The β-Galactosidase ( ) Reaction Is Partly Facilitated by Interactions of His-540 with the C6 Hydroxyl of Galactose. Journal of Biological Chemistry. 271(24). 14296–14301. 25 indexed citations
13.
Roth, Nathan & R.E. Huber. (1994). Site-Directed Substitutions Suggest That His-418 of β-Galactosidase (Escherichia coli) Is a Ligand to Mg2+. Biochemical and Biophysical Research Communications. 201(2). 866–870. 12 indexed citations
14.
Braun, Erik, et al.. (1988). The influence of distraction on coping with stress in dentistry.. PubMed. 30(2). 120–1. 2 indexed citations
15.
Roth, Nathan. (1986). Sigmund Freud's dislike of music: a piece of epileptology.. PubMed. 62(7). 759–65. 3 indexed citations
16.
Roth, Nathan. (1976). The dichotomy of man: Religion vs. science. Journal of Religion and Health. 15(3). 151–158. 1 indexed citations
17.
Kohler, K.J., et al.. (1975). [The significance of physiologic parameters for stress determination in simple directional movements].. PubMed. 21(7). 548–53. 1 indexed citations
18.
Roth, Nathan. (1974). Symbol, Dream, and Psychosis. American Journal of Psychotherapy. 28(1). 146–146. 19 indexed citations
19.
Roth, Nathan. (1967). King George III and Porphyria. American Journal of Psychiatry. 123(7). 866–871. 4 indexed citations
20.
Roth, Nathan. (1964). Psychogenic visual defect and the visual field. Psychiatric Quarterly. 38(1-4). 109–125. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026